Article
Nice, France-Iris Pharma, which specializes in the research and development of preclinical products in the field of ophthalmology, developed a new choroidial neovascularization (CNV) model in rats by using an argon laser.
Nice, France-Iris Pharma, which specializes in the research and development of preclinical products in the field of ophthalmology, developed a new choroidial neovascularization (CNV) model in rats by using an argon laser.
This model is in addition to many other validated animal models with ocular angiogenesis: retinopathy of prematurity hyperoxia in pup mice; retinal vascular permeation, induced by vascular endothelium growth factor in rabbits; and corneal neovascularization models induced by chemical burn (alcohol and sodium hydroxide) in rats, mice, and rabbits, or by corneal sutures in rabbits.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.